NASDAQ:SNNA Sienna Biopharmaceuticals (SNNA) Stock Price, News & Analysis → Mysterious Gold Leverage Just Announced (From Stansberry Research) (Ad) Free SNNA Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$0.11▼$0.1750-Day Range$0.14▼$0.1452-Week Range$0.06▼$3.80Volume13.32 million shsAverage Volume1.87 million shsMarket Capitalization$4.20 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Sienna Biopharmaceuticals alerts: Email Address Ad Stansberry ResearchMysterious Gold Leverage Just AnnouncedWorld's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.Find out what it is and see how you can get in with just a few dollars. About Sienna Biopharmaceuticals Stock (NASDAQ:SNNA)Sienna Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that focuses on the discovery, clinical development, and commercialization of aesthetics and medical dermatology. Its products include Topical by Design platform for patients with inflammatory skin diseases and other dermatologic and aesthetic conditions through SNA-120, SNA-125, and SNA-001. The company was founded by Todd Harris and Frederick C. Beddingfield III on July 27, 2010 and is headquartered in Westlake Village, CA.Read More Ad Stansberry ResearchMysterious Gold Leverage Just AnnouncedWorld's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.Find out what it is and see how you can get in with just a few dollars. SNNA Stock News HeadlinesApril 16, 2024 | msn.comSienna Miller’s wedding and baby number three joyApril 12, 2024 | msn.comSienna Wildgust, NHRA Pro Stock's Youngest Female Racer Is 'Breath of Fresh Air'April 25, 2024 | Stansberry Research (Ad)Mysterious Gold Leverage Just AnnouncedWorld's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.April 9, 2024 | msn.comHollyoaks airs gunshot twist in Sienna Blake storyApril 9, 2024 | msn.comSienna Mapelli Mozzi ‘looks exactly’ like mom Princess BeatriceApril 9, 2024 | msn.comRevealed: Who Princess Beatrice's rarely seen daughter Sienna looks likeApril 8, 2024 | msn.comPrincess Beatrice 'a fantastic mum' to daughter Sienna, stepmum to WolfieApril 6, 2024 | msn.comHollyoaks star Anna Passey fears potential end of Sienna and Ste's friendshipApril 25, 2024 | Stansberry Research (Ad)Mysterious Gold Leverage Just AnnouncedWorld's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.April 2, 2024 | uk.news.yahoo.comHollyoaks confirms hostage drama for Sienna as Warren plan backfiresApril 2, 2024 | msn.comHollyoaks spoiler: Sienna records Warren's confessionApril 2, 2024 | msn.comMorgan Coleman, Sienna Chirieleison, Alexis Kuntz lead Trinity lacrosse past NorthernApril 1, 2024 | msn.comHollyoaks confirms terrifying home invasion as Sienna Blake is held at gunpointMarch 27, 2024 | msn.comFormer Sienna guard Elisa Mevius commits to Oregon women’s basketballMarch 26, 2024 | uk.style.yahoo.comSienna Miller's Missoma earrings are on every A-lister this seasonMarch 25, 2024 | msn.comSienna Miller's affordable earrings are top of our wish listMarch 15, 2024 | msn.comGrandview girls basketball star Sienna Betts named Colorado Gatorade Player of the YearMarch 12, 2024 | msn.comSienna Miller Just Wore A Perfect Rainy Day Outfit, Including One Of Her Favourite High Street BrandsMarch 12, 2024 | msn.comSienna Miller's Missoma earrings are a must-have for the new seasonMarch 10, 2024 | msn.comCiara Celebrates Women’s Day With Sienna in Disneyland as Russell Wilson Fights for NFL FutureMarch 8, 2024 | msn.comSienna Miller, 42, and rarely-seen boyfriend Oli Green, 27, make stunning appearance after welcoming baby girlMarch 7, 2024 | msn.comHollyoaks confirms major death twist for Sienna Blake as dastardly James Nightingale goes too farMarch 5, 2024 | sg.news.yahoo.comEXCLUSIVE: Issa Rae on Her Mission for Healthy Hair Journeys in New Sienna Naturals CampaignMarch 5, 2024 | msn.comSienna Miller just wore the 'cool girl' coat trend of the seasonMarch 4, 2024 | msn.comNail Sienna Miller's $2,798 Leather Trench Style for Under $50March 3, 2024 | msn.comSienna Miller Embraces Love Amidst 14-Year Age Gap with Oli GreenMarch 3, 2024 | yahoo.comFans Are Loving Ciara’s Daughter Sienna’s ‘Daddy Daughter Dance’ With Russell Wilson in Sweet VideoSee More Headlines Receive SNNA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sienna Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/14/2019Today4/25/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical Preparations Sub-IndustryN/A Current SymbolNASDAQ:SNNA CUSIPN/A CIK1656328 Webwww.siennabio.com Phone(818) 629-2256FaxN/AEmployees39Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($3.59) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-73,470,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-177.36% Return on Assets-52.22% Debt Debt-to-Equity RatioN/A Current Ratio15.27 Quick Ratio15.27 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$1.27 per share Price / Book0.11Miscellaneous Outstanding Shares30,908,000Free FloatN/AMarket Cap$4.20 million OptionableNot Optionable Beta2.67 7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report Key ExecutivesFrederick C. BeddingfieldPresident, Chief Executive Officer & DirectorMajed KheirVice President-OperationsPaul F. LizzulChief Medical OfficerSilvio TraversaChief Scientific OfficerTodd J. HarrisDirector & Head-Corporate DevelopmentKey CompetitorsSoligenixNASDAQ:SNGXArtelo BiosciencesNASDAQ:ARTLEnsysce BiosciencesNASDAQ:ENSCHillstream BioPharmaNASDAQ:HILSZyVersa TherapeuticsNASDAQ:ZVSAView All Competitors SNNA Stock Analysis - Frequently Asked Questions How were Sienna Biopharmaceuticals' earnings last quarter? Sienna Biopharmaceuticals, Inc. (NASDAQ:SNNA) posted its quarterly earnings results on Thursday, March, 14th. The company reported ($0.93) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.83) by $0.10. What other stocks do shareholders of Sienna Biopharmaceuticals own? Based on aggregate information from My MarketBeat watchlists, some companies that other Sienna Biopharmaceuticals investors own include SCYNEXIS (SCYX), Allena Pharmaceuticals (ALNA), Spectrum Pharmaceuticals (SPPI), Selecta Biosciences (SELB), Viking Therapeutics (VKTX), Novavax (NVAX), Synergy Pharmaceuticals (SGYP), Zealand Pharma A/S (ZEAL) and Bausch Health Companies (BHC). When did Sienna Biopharmaceuticals IPO? Sienna Biopharmaceuticals (SNNA) raised $64 million in an initial public offering on Thursday, July 27th 2017. The company issued 4,300,000 shares at $14.00-$16.00 per share. J.P. Morgan, Cowen and BMO Capital Markets acted as the underwriters for the IPO. This page (NASDAQ:SNNA) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyYour Money is Not SafeAmerican AlternativeThe only accurate crypto trading system I know …Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sienna Biopharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
